Rhenman & Partners Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-235,210
| Closed | -$2.64M | – | 94 |
|
|
2022
Q4 | $2.64M | Hold |
235,210
| – | – | 0.28% | 76 |
|
|
2022
Q3 | $2.49M | Hold |
235,210
| – | – | 0.26% | 80 |
|
|
2022
Q2 | $1.99M | Hold |
235,210
| – | – | 0.23% | 79 |
|
|
2022
Q1 | $3.2M | Buy |
235,210
+49,000
| +26% | +$667K | 0.32% | 76 |
|
|
2021
Q4 | $3.62M | Hold |
186,210
| – | – | 0.24% | 81 |
|
|
2021
Q3 | $5.98M | Hold |
186,210
| – | – | 0.42% | 66 |
|
|
2021
Q2 | $6.3M | Buy |
186,210
+11,210
| +6% | +$379K | 0.43% | 74 |
|
|
2021
Q1 | $6.57M | Hold |
175,000
| – | – | 0.46% | 61 |
|
|
2020
Q4 | $5.81M | Buy |
+175,000
| New | +$5.81M | 0.47% | 62 |
|